Ukraine to buy 2 mln doses of China's CoronaVac vaccine
Jan 01 2021
China has given conditional approval to a coronavirus vaccine developed by state-owned Sinopharm.
"The inactivated vaccine, developed by Beijing Biological Products Institute under Sinopharm's subsidiary China National Biotec Group (CNBG), got official authorisation from China's National Medical Products Administration on Wednesday", Chen Shifei, deputy head of the National Medical Products Administration, was quoted as saying by the state-run Global Times.
Earlier this month, The United Arab Emirates became the first foreign country to approve a China-developed Covid-19 vaccine, saying it was 86% effective based on interim results of a Phase 3 trial.
China launched an emergency use programme in July aimed at essential workers and others at high risk of infection and has administered more than 4.5 million doses of Sinopharm's two vaccines and Sinovac's CoronaVac. After the COVID-19 vaccines are approved to enter the market, especially when production capacity increases, China will comprehensively vaccinate senior citizens, people with underlying conditions, and the general public in an orderly manner, he said.
The Sinopharm vaccine uses inactivated coronavirus that causes the body to produce antibodies, a more conventional approach to inoculation. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
CanSinoBIO plans to submit clinical trial results for its vaccine to authorities in Mexico next week, a top Mexican health official said.
Practically, the conditional approval means that the drug or product in question may be restricted for certain age groups, according to Tao Lina, a former Shanghai Center for Disease Control immunologist. Officials did not say what proportion of the population they will vaccinate in China.
Both shots have been closely watched by developing countries, many of which have been unable to secure the Pfizer and Moderna doses being snapped up by rich nations.
Turkey received its first shipment of 3 million doses of the Sinovac COVID-19 vaccine on Wednesday, part of a pact for a total of 50 million.
Pakistan is now running phase III clinical trials for CanSino Biologics' vaccine candidate, Ad5-nCoV, led by the government-run National Institute of Health. "And once more data is compiled on human trials and if the country of the vaccine's origin is trustworthy, the vaccine could also have a shot".
China is eager to ship its vaccines globally, driven by a desire to fix the damage to its image caused by the pandemic that started a year ago in the central city of Wuhan.
Brazil has not yet approved a vaccine and there is no clear date to begin a vaccination program.